Key result
The presence of a transvalvular permanent pacemaker lead was not a risk factor for recurrent tricuspid regurgitation, TV-related reoperations, or late mortality after ring annuloplasty.
Why the study?
The impact of permanent pacemaker leads on functional outcome after tricuspid valve repair has not been clearly demonstrated, leading to controversy about lead management during valve repair.
Does the presence of a transvalvular pacemaker lead worsen functional outcomes, reoperation rates, or survival in patients undergoing tricuspid ring annuloplasty for functional TR?
Cohort (n=415)
No
Does the presence of a transvalvular pacemaker lead worsen functional outcomes, reoperation rates, or survival in patients undergoing tricuspid ring annuloplasty for functional TR?
Transvalvular pacemaker leads do not adversely affect recurrent tricuspid regurgitation, reoperation rates, or survival after tricuspid ring annuloplasty for functional TR.
Answers are grounded in this paper and cite their sources.
Supports proceeding with ring annuloplasty despite transvalvular leads; leaves open need for prospective confirmation.
OBJECTIVES: The impact of permanent pacemaker (PPM) leads on functional outcome of tricuspid valve (TV) repair has not been clearly demonstrated. Therefore, controversy exists as to whether transvalvular PPM leads should be explanted and replaced by epicardial leads at the time of valve repair. This study evaluates the influence of PPM leads on functional outcome, TV-related reoperations and survival in patients undergoing TV repair for functional tricuspid regurgitation (TR). METHODS: We retrospectively reviewed 415 consecutive patients who underwent TV ring annuloplasty at our institution from July 2007 to February 2013. In 112 patients (27%), a PPM was implanted either pre- or postoperatively. The follow-up is 94% complete (mean: 24.4 months; cumulative total 845 patient-years). RESULTS: The mean age was 70.2 ± 9.8 years and the mean logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) was 12.4%. Of note, 76.6% of the patients were in New York Heart Association class III or IV. Echocardiography documented moderate or severe TR in 96.4% of the patients, with a mean annulus diameter of 44.8 ± 5.4 mm. 95.4% of the patients underwent a combined procedure and 16.4% an urgent or emergent operation. The 30-day mortality was 7.5%. The preoperative TR grade was reduced from 2.47 ± 0.52 to 0.70 ± 0.54 (P < 0.001). At hospital discharge, residual ≥II TR was present in 7.1% of the patients. Freedom from recurrent ≥II TR at 5 years was 86.7 ± 3.2%. Upon uni- and multivariate analyses, the presence of a transvalvular PPM was not a risk factor for recurrent ≥II TR and late mortality. Freedom from TV-reoperations was 98.1 ± 0.8% at 5 years without significant difference between groups. CONCLUSION: The presence of a transvalvular PPM lead is not a risk factor for recurrent TR, TV-related reoperations and late mortality in patients undergoing ring annuloplasty for functional TR.
No takes yet. Share an insight, caveat, or question.
Ratschiller et al. (2014) conducted a cohort in Functional tricuspid regurgitation (n=415). Transvalvular permanent pacemaker (PPM) lead vs. No transvalvular PPM lead was evaluated on Recurrent ≥II tricuspid regurgitation, TV-related reoperations, and late mortality. The presence of a transvalvular permanent pacemaker lead was not a risk factor for recurrent tricuspid regurgitation, TV-related reoperations, or late mortality after ring annuloplasty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: